Although the antibody-based recognition of cell-surface markers has been widely used for
the identification of immune cells, overlap in the expression of markers by different cell types …

Autoimmune diabetes occurs when invading lymphocytes destroy insulin-producing β cells
in pancreatic islets. The role of lymphocytic aggregates at this inflammatory site is not …

Bruton’s tyrosine kinase (BTK) mediates B cell signaling and is also present in innate
immune cells but not T cells. BTK propagates B cell receptor (BCR) responses to antigen-…

Inborn errors of immunity (IEI) are a genetically heterogeneous group of disorders with a
broad clinical spectrum. Identification of molecular and functional bases of these disorders is …

Autoreactive B lymphocytes that are not culled by central tolerance in the bone marrow
frequently enter the peripheral repertoire in a state of functional impairment, termed anergy. …

Interstitial lung disease (ILD) remains a cause of significant morbidity and mortality in patients
with connective tissue disease (CTD)–associated ILD. While some patients meet clear …

Lymphocytes that invade nonlymphoid tissues often organize into follicle-like structures known
as tertiary lymphoid organs (TLOs). These structures resemble those found in spleen or …

Immune cells have been implicated in idiopathic pulmonary fibrosis (IPF), but the phenotypes
and effector mechanisms of these cells remain incompletely characterized. We performed …

Individuals with primary antibody deficiency (PAD) syndromes have poor humoral immune
responses requiring immunoglobulin replacement therapy. We followed individuals with PAD …

Bruton’s tyrosine kinase (Btk) is a crucial regulator of B cell signaling and is a therapeutic
target for lymphoma and autoimmune disease. BTK-deficient patients suffer from humoral …